College aantekeningen
Cursus Reumatologie
5 keer bekeken
0 keer verkocht
Volledige uitwerking reumatologie (REVAKI UGent)
[Meer zien]
Voorbeeld 4 van de 168 pagina's
Geupload op
30 oktober 2022
Aantal pagina's
168
Geschreven in
2021/2022
Type
College aantekeningen
Docent(en)
/
Bevat
Alle colleges
€5,99
100% tevredenheidsgarantie
Direct beschikbaar na betaling
Zowel online als in PDF
Je zit nergens aan vast
2021
Revalidatie en kinesitherapie bij
reumatologische aandoeningen
3DE BACHELOR REVALIDATIEWETENSCHAPPEN EN KINESITHERAPIE
UGENT
STIJN DEBUF
,REUMATOLOGIE – 3DE BACHELOR REVAKI UGENT
Revalidatie bij reumatologische aandoeningen
3de bachelor Revalidatiewetenschappen en Kinesitherapie – Universiteit Gent
1
,REUMATOLOGIE – 3DE BACHELOR REVAKI UGENT
INHOUDSTAFEL
Hoofdstuk 1 ....................................................................................................................................................................................... 6
Inleiding reumatologische aandoeningen en bindweefselziekten................................................................. 6
Reumatische systeemziekten of bindweefselziekten .................................................................................... 9
Systeemlupus .................................................................................................................................................. 9
Sjögren syndroom ......................................................................................................................................... 11
Polymyalgia reumatica .................................................................................................................................. 12
Idiopathische inflammatoire myositis ........................................................................................................... 13
Systeemsclerose ............................................................................................................................................ 14
Neoplasie – oncologie in de reumatologie .................................................................................................. 17
Bottumoren ................................................................................................................................................... 17
Paraneoplastische syndromen ...................................................................................................................... 19
Voorbeeldcasussen ....................................................................................................................................... 21
Hoofdstuk 2 ..................................................................................................................................................................................... 23
Osteoartritis (OA) ....................................................................................................................................... 23
Etiologie (OA) ................................................................................................................................................ 23
Epidemiologie en risicofactoren (OA) ........................................................................................................... 27
Diagnostiek (OA) ........................................................................................................................................... 28
Subtypes (OA)................................................................................................................................................ 30
Medische behandeling (OA) .......................................................................................................................... 32
Revalidatie (OA) ............................................................................................................................................ 35
Hoofdstuk 3 ..................................................................................................................................................................................... 49
Reumatoïde artritis (RA) ............................................................................................................................. 49
Inleiding (RA) ................................................................................................................................................. 49
Klinische manifestaties (RA) .......................................................................................................................... 49
Etiologie (RA) ................................................................................................................................................. 52
Diagnose (RA) ................................................................................................................................................ 53
Medische behandeling (RA) .......................................................................................................................... 58
Septische artritis (SA) ................................................................................................................................. 62
Inleiding (SA) ................................................................................................................................................. 62
Etiologie (SA) ................................................................................................................................................. 62
Diagnose (SA) ................................................................................................................................................ 63
Medische behandeling (SA)........................................................................................................................... 64
Kristalartritis (KA) ....................................................................................................................................... 66
Inleiding (KA) ................................................................................................................................................. 66
Etiologie JICHT ............................................................................................................................................... 66
2
, REUMATOLOGIE – 3DE BACHELOR REVAKI UGENT
Prevalentie JICHT........................................................................................................................................... 67
Diagnose JICHT .............................................................................................................................................. 67
Medische behandeling JICHT ........................................................................................................................ 68
Etiologie PSEUDOJICHT ................................................................................................................................. 69
Diagnose PSEUDOJICHT................................................................................................................................. 69
Medische behandeling PSEUDOJICHT ........................................................................................................... 70
Hoofdstuk 4 ..................................................................................................................................................................................... 71
Avasculaire necrose (aseptische necrose) ................................................................................................... 71
Inleiding ......................................................................................................................................................... 71
Symptomen ................................................................................................................................................... 72
Diagnostiek.................................................................................................................................................... 73
Oorzaken ....................................................................................................................................................... 76
Medische behandeling .................................................................................................................................. 78
Revalidatie ..................................................................................................................................................... 79
Hoofdstuk 5 ..................................................................................................................................................................................... 81
Abarticulaire klachten ................................................................................................................................ 81
Inleiding ......................................................................................................................................................... 81
Periartritis scapulohumeralis (PSH) ............................................................................................................... 81
Carpaaltunnel syndroom (CTS) ..................................................................................................................... 84
Kniekuilcyste (Baker’s Cyst) ........................................................................................................................... 86
Hoofdstuk 6 ..................................................................................................................................................................................... 88
Osteoporose ............................................................................................................................................... 88
Inleiding ......................................................................................................................................................... 88
Symptomatologie .......................................................................................................................................... 89
Diagnose ........................................................................................................................................................ 91
Pathogenese.................................................................................................................................................. 94
Preventie en therapie.................................................................................................................................... 96
Revalidatie bij osteoporose ......................................................................................................................... 104
Hoofdstuk 7 .................................................................................................................................................................................. 113
Spondyloartritis (SpA) .............................................................................................................................. 113
Inleiding SpA................................................................................................................................................ 113
Concept SpA ................................................................................................................................................ 119
Prevalentie SpA ........................................................................................................................................... 120
Algemene kenmerken SpA .......................................................................................................................... 121
Specifieke ziektebeelden SpA ..................................................................................................................... 128
Patient-partner program SpA ...................................................................................................................... 145
Revalidatie SpA............................................................................................................................................ 146
3